ArticleDiagnostics (Basel, Switzerland)2023
Impact of [
Shaghayegh Ranjbar, Seyed Rasoul Zakavi, Roya Eisazadeh, Seyed Ali Mirshahvalad, Julia Pilz, Zahra Jamshidi-Araghi, Gregor Schweighofer-Zwink, Peter Koelblinger, Christian Pirich, Mohsen Beheshti
Open access · goldAbstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 3 institutions in 3 countries.
Shaghayegh RanjbarDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-7806-7921 Seyed Rasoul ZakaviNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad 13944-91388, Iran.ORCID 0000-0002-8276-2134 Roya EisazadehDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
Seyed Ali MirshahvaladDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0003-2271-9764 Julia PilzDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
Zahra Jamshidi-AraghiDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
Gregor Schweighofer-ZwinkDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.
Peter KoelblingerDepartment of Dermatology, University Hospital, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-5897-2780 Christian PirichDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0002-4502-0609 Mohsen BeheshtiDivision of Molecular Imaging & Theranostics, Department of Nuclear Medicine, University Hospital Salzburg, Paracelsus Medical University, 5020 Salzburg, Austria.ORCID 0000-0003-3918-3812 Paracelsus Medical University · ATMashhad University of Medical Sciences · IRUniversity Health Network · CA
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
We aimed to investigate the role of [
Indexed as
FDGimmunotherapymelanomaPET/CTvasculitis
Identifiers
PMID37175008
PMCPMC10178249
OpenAlexW4368367270
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390